.fr
.zh
.deYou are here : Homepage > Live > Testimonies > Sectors of excellence
Testimonies - Life sciences
- Testimony of Aurélien LUGARDON
Président directeur général, Naskeo Environnement
Naskeo Environnement, the waste-processing experts more
- Testimony of David SOURDIVE
Chief Executive Officer, Cellectis
CELLECTIS R&D in genome engineering more
- Testimony of Dinah WEISSMAN
Founder and CEO, Biocortech
BIOCORTECH working on neuropsychiatriques disorders more
- Testimony of Dominique COSTANTINI
President and CEO, BioAlliance Pharma
BioAlliance Pharma, "speciality pharma" targetng cancer and infections. more
- Testimony of Dominique SURUN
Chief Executive Officer, ATEROVAX
ATEROVAX specialist in atherosclerosis research more
- Testimony of Françoise SOUSSALINE
President and Founder, IMSTAR
IMSTAR the cellular imaging specialist more
- Testimony of Gregory LEMKINE
CEO, WatchFrog
WATCHFROG in vivo detection of active chemical substances more
- Testimony of Iain BUCHANAN
Chief Executive Officer, Novexel
NOVEXEL researching antibiotics to threat severe infections more
- Testimony of Jean PACHOT
Chairman and Scientific Director, Oroxcell
OROXCELL, the bioavailability specialist more
- Testimony of Jean-Michel MAUCLAIRE
CEO, Bioquanta
BIOQUANTA, specialist in molecular modelling more
- Testimony of Laurent FULLAMA
Chief Executive Officer, AirInSpace
AIRINSPACE biotech company dedicated to air decontamination more
- Testimony of Marie MEYNADIER
CEO, Biospace Med
Biospace Med, dedicated to ultra low dose osteo-articular imaging more
- Testimony of Stéphane DEGOVE
Head of Finance, Endotis Pharma
ENDOTIS PHARMA, specialist R&D in samll glyco drugs more
- Testimony of Dr Catherine LASSALE
Scientific, pharmaceutical and medical affairs director - LEEM
France has traditionally been a major force in biology, medicine and pharmaceuticals. According to the updated survey Biomédicaments 20101, conducted in 2006, France’s scientific and technical environment is still regarded as attractive. more
- Testimony of Fabien CALVO
Director of scientific research at INCa (french national cancer institute)
A large number of anti-cancer drugs (CPT-11, Oxaliplatine, Taxotere, Navelbine, Sunitinib, etc.) were developed in France from Phase I onwards. more
- Testimony of Laurent LEVY
Chairman and managing Director - Nanobiotix
Biotechnology and biotech companies need several key ingredients in order to maximise their chances of success. more
- Testimony of Marc PESCHANSKI
Leader of unit INSERM/UEVE/AFM U86 - I-STEM
With nearly a dozen clinical investigation centres (CICs) specialising in transferring the results of experimental research to patients, Paris Region is one of the world’s best-equipped platforms for translational therapeutic research programmes. more
- Testimony of Pr José-Alain SAHEL
Director of the Institut de la Vision
The Institut de la Vision will give ophthalmological research in France an integrated facility bringing together a critical mass of researchers and clinicians,... more
update July 16, 2008
Competitiveness cluster
Life sciences in Paris Region
pdf | 2034 kB
Download brochure
Econovista.com
